Abderrahim Benmoussa, phDApr 7, 20202 minExperimental treatments and controversies, a reviewQuality of evidence: C Controversial treatments: an updated understanding of the Coronavirus Disease 2019 Authors: Zhang C et al Journal:...
Abderrahim Benmoussa, phDApr 7, 20201 minHeparin and mortality in patients with coagulopathy, a retrospective cohort studyQuality of evidence: B- Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with...
Abderrahim Benmoussa, phDApr 6, 20201 minEarly use of short term corticosteroids therapy, an open-label non-randomized monocentric trialQuality of evidence: C- Early, low-dose and short-term application of corticosteroid treatment in patients with severe COVID-19...
Abderrahim Benmoussa, phDApr 6, 20201 minAnti-inflammatory drugs and severe cases, a review, and expert position from ChinaQuality of evidence: C+ The Use of Anti-Inflammatory Drugs in the Treatment of People With Severe Coronavirus Disease 2019 (COVID-19):...